Allotment of 1.61 crore shares via share swap to acquire iSERA Biological Limited

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Next day

₹143.90

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+1.3% vs market

Computers - Software & Consulting peers, median of 67sector-1.3%+1.3% vs sector

By the next day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.3 pts more than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-1.3—-0.9—

Next day

+0.0-1.3+1.3-1.3+1.3

+0.0+0.0-0.0-0.7+0.7

—-0.2—-0.7—

+0.0-3.0+3.0-2.9+2.9

—-2.7—-1.5—

+0.0-1.7+1.7-0.1+0.1

15d

+0.0-8.9+8.9-4.1+4.1

—————

UpDownMarket · Nifty Microcap 250Sector · Computers - Software & Consulting peers, median of 67Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board allotted 1,61,82,800 equity shares at Rs 48.20 each (including Rs 38.20 premium) to 196 allottees via a preferential share swap with shareholders of iSERA Biological Limited at a 1:1 ratio. No cash is involved. Post-allotment paid-up capital nearly triples to 2,45,91,772 shares from 84,08,972. Allottees include promoters, promoter group, several funds and HNIs.

Likely market impact

Share count nearly triples, causing dilution, but no cash leaves the company. Effectively merges iSERA Biological into the listed entity.